Alpha Cognition EPS - Earnings per Share 2020-2024 | ACOG

Alpha Cognition eps - earnings per share from 2020 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Alpha Cognition Annual EPS
2023 $-0.15
2022 $-0.18
2021 $-0.37
2020 $-0.13
2019 $-0.21
Alpha Cognition Quarterly EPS
2024-06-30 $-0.01
2024-03-31 $-0.03
2023-12-31 $-0.07
2023-09-30 $-0.03
2023-06-30 $-0.03
2023-03-31 $-0.02
2022-12-31 $-0.05
2022-09-30 $-0.04
2022-06-30 $-0.05
2022-03-31 $-0.04
2021-12-31 $-0.01
2021-09-30 $-0.08
2021-06-30 $0.00
2021-03-31 $-0.28
2020-12-31 $-0.04
2020-09-30 $-0.03
2020-06-30 $-0.04
2020-03-31 $-0.02
2019-12-31 $0.00
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.035B $0.000B
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
BioHarvest Sciences (BHST) Canada $0.098B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00